AzTrials
AzTrials

Suicide PreventionHOPAIRNCT07119671

Feasibility Study of a Combined Intervention for Suicidal Inpatients in Psychiatric Crisis Units.

A study testing HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis Unit in people with Suicide Prevention, run by Hôpital le Vinatier at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Since 2014, suicide prevention has been a national priority and is one of the 3 priority areas of the mental health plan's roadmap . Hospitalization offers a crucial opportunity for life-preserving intervention . Brief health interventions and contacts are reputed to be easy to implement, effective and inexpensive . Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicide Prevention
What is being tested?
HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis Unit
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteFrance
Study dates
24 Sep 2025to 15 Oct 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Major ;
  • Hospitalized in a psychiatric crisis unit;
  • Having attempted suicide in the month preceding hospitalisation;
  • Able to give free and informed consent;
  • Having given consent;
  • French-speaking person with at least B1 level (reading and writing);
  • With access to the technical resources required for the study;
  • With a postal address.

Who cannot join

  • Presenting a relational modality incompatible with the proposed intervention (agitation, acute delirium, major cognitive disorders or psychic disorganisation, etc.);
  • Included in another research protocol related to suicide prevention.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Centre Hospitalier Le Vinatier

    Bron, AURA, 69678 CEDEX

    POULET EMMANUEL, PUPH, 0033437915120, emmanuel.poulet@chu-lyon.fr

    VIAL VERONIQUE, 0033437915531, veronique.vial@ch-le-vinatier.fr

    Recruiting

Other trials in France

About this study

Official title: Peer-Aid and Hope Box: A Feasibility Study of a Combined Intervention for Suicidal Patients Hospitalized in a Psychiatric Crisis Unit

Since 2014, suicide prevention has been a national priority and is one of the 3 priority areas of the mental health plan's roadmap .

Hospitalization offers a crucial opportunity for life-preserving intervention . Brief health interventions and contacts are reputed to be easy to implement, effective and inexpensive .

Read more

The Hope Box is a practical emotional management tool that aims to encourage the expression of reasons for living by materializing them in a customizable box, filled with objects, photos, writings and memories in order to find comfort and hope .

Peer support use their experiential knowledge of disorders and recovery to accompany people and help humanize care . They can play a decisive role in suicide prevention .

In contrast to an approach focusing only on risk factors, peer support and the Hope Box are both focus on protective factors, the strengths of the people concerned and hope.

The primary objective of this study is to evaluate the feasibility of the HOPAIR intervention (peer-support and Hope Box, completed by a reminder postcard) with suicidal people hospitalized in psychiatric crisis units. Its secondary objective is to assess the potential effectiveness on intensity of hopelessness, sense of self-efficacy, reasons for living, perceived social support and suicidal recurrence at 3 months.

This is a mixed-methods study involving 40 patients and 2 peer support in two crisis hospitalization units.

Read the detailed description

Around 703,000 people die by suicide each year worldwide, with suicide prevention being a national priority in France since 2014. The period after a patient is discharged from the hospital is a particularly high-risk time for suicide, especially for those with a history of suicide attempts.

This study proposes a new intervention called HOPAIR, which combines three key components:

  • Peer support: A professional peer-helper, who has personal experience with mental health challenges, meets with the patient to share their recovery story and foster a sense of hope and connection.
  • The Hope Box: A personalized box that patients fill with objects, photos, and memories to engage their five senses and serve as a tool for emotional management, comfort, and distraction during times of distress.
  • A reminder postcard: Sent one month after the initial intervention to reinforce the key concepts of the Hope Box and maintain motivation.

The primary objective of the HOPAIR study is to evaluate the feasibility of this combined intervention for suicidal patients hospitalized in a psychiatric crisis unit. The study also aims to assess the potential effectiveness of HOPAIR on several factors after three months, including:

  • Feelings of hopelessness and self-efficacy
  • Reasons for living
  • Perceived social support
  • The presence of suicidal thoughts and repeat suicide attempts The study is a mixed-methods, bi-centric research project that will recruit patients 24-48 hours after admission. The intervention will take place within two to four days of admission, followed by the postcard mailing one month later, and a final evaluation at three months. This evaluation will include re-administering scales to measure the study's objectives and conducting qualitative interviews with a subset of participants to assess their satisfaction with the program.
Being tested
HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis Unit
Keywords
Suicide prevention, Hope box, Pair aid
Medical subject headings
Suicide Prevention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis UnitOther

    This intervention begins with an initial discussion focused on the individual's lived experience, followed by an explanation of the Hope Box's principle, utility, and use. After each intervention, the peer supporter will complete a satisfaction self-questionnaire to provide feedback.

Study groups in NCT07119671
Study groupRoleWhat they receive
HOPAIR Intervention: Meeting between Peer helper and Concerned Individual in Psychiatric Crisis UnitOtherThis intervention begins with an initial discussion focused on the individual's lived experience, followed by an explanation of the Hope Box's principle, utility, and use. After each intervention, the peer supporter will complete a satisfaction self-questionnaire to provide feedback.
Receives: Other: HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis Unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility Evaluation of the Combined HOPAIR Intervention (Peer Support, Hope Box, and Postcard Reminder) for Suicidal Inpatients in Psychiatric Crisis Units at 3-Month Post-Intervention.

    It will be assessed by :

    • Achievement of the target of recruiting two peer support (yes/no).
    • Completion of training by the two peer support (yes/no).
    • Recruitment capacity of 40 patients, 20 in each center;
    • Collection and description of the characteristics of the resulting sample at the time of inclusion by the IPA within 24 hours of arrival in the department;
    • The acceptability of the intervention and the use of the Hope Box through feedback from the people concerned by means of a semi-directive telephone interview at 3 months by the IPA;
    • Feedback from peer support after each intervention, using self-questionnaires;

    Measured: 37 months

Secondary outcomes (2)
  1. Effectiveness of the HOPAIR intervention on indicators of well-being at 3 months post-intervention.

    The potential effectiveness of the HOPAIR system will be assessed by comparing the differences in scores and responses to questions at inclusion, during a face-to-face interview and at 3 months after the HOPAIR intervention during a telephone interview by the IPA using the following scales and questions.

    Measured: 37 months

  2. Effectiveness of the HOPAIR intervention on indicators of suicidality at 3 months post-intervention.

    The potential effectiveness of the HOPAIR system will be assessed by comparing the differences in scores and responses to questions at inclusion, during a face-to-face interview and at 3 months after the HOPAIR intervention during a telephone interview by the IPA using the following scales and questions

    Measured: 37 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start24 Sep 2025
  3. Primary completion15 Oct 2028 (estimated)
  4. Study completion15 Oct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
Mixed bi-centric
Masking
None (open label)
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07119671
Sponsor's protocol ID
2025-A00082-47
Acronym
HOPAIR
Status last verified
Oct 2025
First submitted
29 Jul 2025
Last updated
21 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing HOPAIR Intervention: Meeting between Peer Helper and Concerned Individual in Psychiatric Crisis Unit in people with Suicide Prevention, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tamara VERNET, IPA (00334 37 91 52 10, Tamara.vernet@ch-le-vinatier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility Evaluation of the Combined HOPAIR Intervention (Peer Support, Hope Box, and Postcard Reminder) for Suicidal Inpatients in Psychiatric Crisis Units at 3-Month Post-Intervention. (time frame: 37 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in